Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renexin for recurrent vestibulopathy (randomized placebo-controlled exploratory study)
KCT0000987Phase 3Recruiting
- Sponsor
- SK Chemicals
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol + ginkgo leaf extract in recurrent vestibulopathy (RV), sponsored by SK Chemicals. Started Aug 2013; status: recruiting.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
recurrent vestibulopathy (RV)
Beyond the preview
Go deeper on KCT0000987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000987.